Clinical investigation of Multispectral Optoacoustic Tomography for monitoring neoadjuvant therapy in breast cancer. (A01)

点击翻译按钮获取中文摘要

A1 is dedicated to the clinical assessment of multispectral optoacoustic tomography (MSOT), in particular in the context of in vivo breast imaging to determine endogenous biomarkers suitable for early prediction of response to neoadjuvant therapy. By utilizing a hybrid handheld MSOT and ultrasound imaging modality, A1 will further evaluate the MSOT ability to complement the diagnostic performance of breast ultrasound. We hypothesize that visualizing and monitoring of functional and molecular signals in human breast will lead to improvements in treatment performance by allowing for individual therapy adaptation early on.